Abstract
The influence of altered drug binding on the hepatic elimination of tolbutamide, a drug of low intrinsic clearance, and on the formation of its metabolite, hydroxytolbutamide, was examined under linear conditions at steady state in the isolated in situsingle-pass perfused rat liver preparation, with perfusate flow fixed at 15 ml/min. The fraction of tulbutamide unbound in the perfusate was varied (from 0.06 to 1.0) by either varying the perfusate concentration of albumin or using albumin of different animal species. The intrinsic clearance of tolbutamide varied fourfold between preparations (0.08–0.36 ml/min/g liver). Within each preparation the data were normalized to observations with a perfusate containing no protein. Both the extraction ratio (and clearance) of tolbutamide and the fraction of tulbutamide appearing as hydroxytolbutamide in effluent perfusate, a measure of hepatic metabolism, were directly proportional to the fraction of tolbutamide unbound in the perfusate.
Similar content being viewed by others
References
G. R. Wilkinson and D. G. Shand. Commentary. A physiological approach to hepatic drug clearance.Clin. Pharmacol. Ther. 18:377–390 (1975).
T. N. Tozer. Concepts basic to pharmacokinetics.Pharmacol. Ther. 12:109–132 (1981).
G. Levy and A. Yacobi. Effect of plasma protein binding on elimination of warfarin.J. Pharm. Sci. 63:805–706 (1974).
R. Gugler, D. W. Shoeman, D. H. Huffman, J. B. Cohlmia, and D. L. Azarnoff. Pharmacokinetics of drug in patients with the nephrotic syndrome.J. Clin. Invest. 55:1182–1186 (1975).
D. G. Shand, R. H. Cotham, and G. R. Wilkinson. Perfusion-limited effects of plasma drug binding in hepatic drug extraction.Life Sci. 19:125–130 (1976).
C-M. Lai and G. Levy. Comparative pharmacokinetics of coumarin anticoagulants. XXX. Relationship between total clearance and serum protein binding of dicoumarol in rats.J. Pharm. Sci. 66:1739–1741 (1977).
T. W. Guentert and S. Øie. Effect of plasma protein binding on quinidine kinetics in the rabbit.J. Pharmacol. Exp. Ther. 215:165–171 (1980).
D. Trenk and E. Jähnchen. Effect of serum protein binding on pharmacokinetics and anticoagulant activity on phenprocoumon in rats.J. Pharmacokin. Biopharm. 8:177–191 (1980).
R. C. Thomas and G. J. Ikeda. The metabolic fate of tolbutamide in man and in the rat.J. Med. Chem. 9:507–510 (1966).
J. Tagg, D. M. Yasula, M. Tanake, and C. Mitoma. Metabolic studies of tolbutamide in the rat.Biochem. Pharmacol. 16:143–153 (1967).
K. S. Pang and M. Rowland. Hepatic clearance of drugs II. Experimental evidence for acceptance of the “well-stirred” model over the “parallel tube” model using lidocaine in the perfused rat liverin situ preparation.J. Pharmacokin. Biopharm. 5:655–680 (1977).
S. B. Matin and M. Rowland. Simultaneous determination of tolbutamide and its metabolities in biological fluids.Anal. Lett. 6:865–876 (1973).
H. Lowry, N. J. Rosenbrough, A. L. Farr, and R. J. Randall. Protein measurements with the Folin regent.J. Biol. Chem. 193:193–275 (1951).
K. S. Pang and M. Rowland. Hepatic clearance of drugs I. Theoretical considerations of a “well-stirred” model and a “parallel tube” model. Influence of hepatic blood flow, plasma and blood cell binding, and the hepatocellular enzymatic activity on hepatic drug clearance.J. Pharmacokin. Biopharm. 5:625–653 (1977).
B. D. Ross.Perfusion Techniques in Biochemistry: A Laboratory Manual. Clarendon Press, Oxford, 1972.
J. Judis. Binding of sulfonylureas to serum proteins.J. Pharm. Sci. 61:89–93 (1972).
Author information
Authors and Affiliations
Additional information
The authors wish to thank Ciba-Geigy (UK) for financial support.
Rights and permissions
About this article
Cite this article
Schary, W.L., Rowland, M. Protein binding and hepatic clearance: Studies with tolbutamide, a drug of low intrinsic clearance, in the isolated perfused rat liver preparation. Journal of Pharmacokinetics and Biopharmaceutics 11, 225–243 (1983). https://doi.org/10.1007/BF01061866
Received:
Revised:
Published:
Issue Date:
DOI: https://doi.org/10.1007/BF01061866